These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26550540)

  • 1. Tumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts.
    Gerber DE; Hao G; Watkins L; Stafford JH; Anderson J; Holbein B; Öz OK; Mathews D; Thorpe PE; Hassan G; Kumar A; Brekken RA; Sun X
    Am J Nucl Med Mol Imaging; 2015; 5(5):493-503. PubMed ID: 26550540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of bavituximab and its potential in the treatment of non-small-cell lung cancer.
    Stasi I; Cappuzzo F
    Lung Cancer (Auckl); 2014; 5():43-50. PubMed ID: 28210141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatment.
    DeRose P; Thorpe PE; Gerber DE
    Immunotherapy; 2011 Aug; 3(8):933-44. PubMed ID: 21843081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer.
    Digumarti R; Bapsy PP; Suresh AV; Bhattacharyya GS; Dasappa L; Shan JS; Gerber DE
    Lung Cancer; 2014 Nov; 86(2):231-6. PubMed ID: 25236982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel Combined With Bavituximab in Previously Treated, Advanced Nonsquamous Non-Small-Cell Lung Cancer.
    Gerber DE; Spigel DR; Giorgadze D; Shtivelband M; Ponomarova OV; Shan JS; Menander KB; Belani CP
    Clin Lung Cancer; 2016 May; 17(3):169-76. PubMed ID: 27265742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of
    Banerjee SR; Kumar V; Lisok A; Plyku D; Nováková Z; Brummet M; Wharram B; Barinka C; Hobbs R; Pomper MG
    J Nucl Med; 2019 Mar; 60(3):400-406. PubMed ID: 30237212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
    Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ
    J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer.
    Ehlerding EB; England CG; Majewski RL; Valdovinos HF; Jiang D; Liu G; McNeel DG; Nickles RJ; Cai W
    Mol Pharm; 2017 May; 14(5):1782-1789. PubMed ID: 28388076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer.
    Gerber DE; Horn L; Boyer M; Sanborn R; Natale R; Palmero R; Bidoli P; Bondarenko I; Germonpre P; Ghizdavescu D; Kotsakis A; Lena H; Losonczy G; Park K; Su WC; Tang M; Lai J; Kallinteris NL; Shan JS; Reck M; Spigel DR
    Ann Oncol; 2018 Jul; 29(7):1548-1553. PubMed ID: 29767677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase Ib Study of Bavituximab With Carboplatin and Pemetrexed in Chemotherapy-Naive Advanced Nonsquamous Non-Small-Cell Lung Cancer.
    Grilley-Olson JE; Weiss J; Ivanova A; Villaruz LC; Moore DT; Stinchcombe TE; Lee C; Shan JS; Socinski MA
    Clin Lung Cancer; 2018 Jul; 19(4):e481-e487. PubMed ID: 29631965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors.
    Kumar SR; Deutscher SL
    J Nucl Med; 2008 May; 49(5):796-803. PubMed ID: 18413389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine.
    Jennewein M; Lewis MA; Zhao D; Tsyganov E; Slavine N; He J; Watkins L; Kodibagkar VD; O'Kelly S; Kulkarni P; Antich PP; Hermanne A; Rösch F; Mason RP; Thorpe PE
    Clin Cancer Res; 2008 Mar; 14(5):1377-85. PubMed ID: 18316558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer.
    Chalasani P; Marron M; Roe D; Clarke K; Iannone M; Livingston RB; Shan JS; Stopeck AT
    Cancer Med; 2015 Jul; 4(7):1051-9. PubMed ID: 25826750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids.
    He J; Luster TA; Thorpe PE
    Clin Cancer Res; 2007 Sep; 13(17):5211-8. PubMed ID: 17785577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma.
    Cheal SM; Xu H; Guo HF; Patel M; Punzalan B; Fung EK; Lee SG; Bell M; Singh M; Jungbluth AA; Zanzonico PB; Piersigilli A; Larson SM; Cheung NV
    Theranostics; 2018; 8(18):5106-5125. PubMed ID: 30429889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of 111In- or 64Cu-DOTA-trastuzumab Fab fragments for imaging subcutaneous HER2-positive tumor xenografts in athymic mice using microSPECT/CT or microPET/CT.
    Chan C; Scollard DA; McLarty K; Smith S; Reilly RM
    EJNMMI Res; 2011 Aug; 1(1):15. PubMed ID: 22214307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors.
    Gerber DE; Stopeck AT; Wong L; Rosen LS; Thorpe PE; Shan JS; Ibrahim NK
    Clin Cancer Res; 2011 Nov; 17(21):6888-96. PubMed ID: 21989064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer.
    Cheal SM; Fung EK; Patel M; Xu H; Guo HF; Zanzonico PB; Monette S; Wittrup KD; Cheung NV; Larson SM
    J Nucl Med; 2017 Nov; 58(11):1735-1742. PubMed ID: 28705917
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.